EUVIMEDEUVIMED entdecken
Crossref

pH-responsive size-adjustable liposomes induce apoptosis of fibroblasts and macrophages for rheumatoid arthritis treatment

Xiu Zheng, Hong Yang, Zongquan Zhang, Xiaoya Liang, Yan Liu, Chenglong Wang, Xi Yang, Jun Tang, Jingying Mao, Yu Nie, Xiangyu Zhou, Chunhong Li

Acta Biomaterialia · 2024-04 · 179 · 256-271

DOI: 10.1016/j.actbio.2024.03.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2024-04. Verfasst von Xiu Zheng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, 646000, China; Drug laboratory, Department …. Hauptthemen laut MEDLINE: Liposomes, Arthritis, Rheumatoid, Fibroblasts, Methotrexate. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Sichuan Province Science and Technology Support Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In rheumatoid arthritis (RA), macrophages infiltrate joints, while fibroblast-like synovial cells proliferate abnormally, forming a barrier against drug delivery, which hinders effective drug delivery to joint focus. Here we firstly designed a pH-responsive size-adjustable nanoparticle, composed by methotrexate (MTX)-human serum albumin (HSA) complex coating with pH-responsive liposome (Lipo/MTX-HSA) for delivering drugs specifically to inflamed joints in acidic environments. We showed in vitro that the nanoparticles can induce mitochondrial dysfunction, promote apoptosis of fibroblast-like synoviocytes and macrophages, further reduce the secretion of inflammatory factors (TNF-α, IL-1β, MMP-9), and regulate the inflammatory microenvironment. We also demonstrated similar effects in a rat model of arthritis, in which Lipo/MTX-HSA accumulated in arthritic joints, and at low pH, liposome phospholipid bilayer cleavage released small-sized MTX-HSA, which effectively reduced the number of fibroblast-synoviocytes and macrophages in joints, alleviated joint inflammation, and repaired bone erosion. These findings suggest that microenvironment-responsive size-adjustable nanoparticles show promise as a treatment against rheumatoid arthritis. STATEMENT OF SIGNIFICANCE: Abnormal proliferation of fibroblast synoviocytes poses a physical barrier to effective nanoparticle delivery. We designed size-adjustable nano-delivery systems by preparing liposomes with cholesterol hemisuccinate (CHEM), which were subsequently loaded with small-sized albumin nanoparticles encapsulating the cytotoxic drug MTX (MTX-HSA), termed Lipo/MTX-HSA. Upon tail vein injection, Lipo/MTX-HSA could be aggregated at the site of inflammation via the ELVIS effect in the inflamed joint microenvironment. Specifically, intracellular acidic pH-triggered dissociation of liposomes promoted the release of MTX-HSA, which was further targeted to fibroblasts or across fibroblasts to macrophages to exert anti-inflammatory effects. The results showed that liposomes with adjustable particle size achieved efficient drug delivery, penetration and retention in joint sites; the strategy exerted significant anti-inflammatory effects in the treatment of rheumatoid arthritis by inducing mitochondrial dysfunction to promote apoptosis in fibrosynoviocytes and macrophages.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiposomesArthritis, RheumatoidFibroblastsMethotrexateApoptosisMacrophagesAnimalsHydrogen-Ion ConcentrationHumansRatsRats, Sprague-DawleyMiceParticle SizeMaleSynoviocytesRAW 264.7 CellsSerum Albumin, HumanNanoparticles

Stichwörter der Autor:innen

Fibroblast-like synovial cellsMacrophagesRheumatoid arthritisSize-adjustablepH-responsive liposome

Substanzen

LiposomesMethotrexateSerum Albumin, Human

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, 646000, China; Drug laboratory, Department of pharmacy, Chengdu Xinhua Hospital affiliated to North Sichuan Medic…
  • Department of Pediatrics, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, China.
  • Department of Pharmaceutical Sciences, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, 646000, China.
  • Analysis and Testing Center, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, 646000, China.
  • Department of Thyroid Surgery, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, China.
  • National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, Sichuan, 610064, China. Electronic address: nie_yu@scu.edu.cn.

Förderung

  • Sichuan Province Science and Technology Support Program

Zitieren

APA

Zheng, X., Yang, H., Zhang, Z., Liang, X., Liu, Y., Wang, C., Yang, X., Tang, J., Mao, J., Nie, Y., Zhou, X., & Li, C. (2024). pH-responsive size-adjustable liposomes induce apoptosis of fibroblasts and macrophages for rheumatoid arthritis treatment. Acta Biomaterialia, 179, 256-271. https://doi.org/10.1016/j.actbio.2024.03.006

Vancouver

Zheng X, Yang H, Zhang Z, Liang X, Liu Y, Wang C, et al. pH-responsive size-adjustable liposomes induce apoptosis of fibroblasts and macrophages for rheumatoid arthritis treatment. Acta Biomaterialia. 2024;179:256-271. doi:10.1016/j.actbio.2024.03.006

BibTeX
@article{Zheng2024,
  author = {Zheng, Xiu and Yang, Hong and Zhang, Zongquan and Liang, Xiaoya and Liu, Yan and Wang, Chenglong and Yang, Xi and Tang, Jun and Mao, Jingying and Nie, Yu and Zhou, Xiangyu and Li, Chunhong},
  title = {pH-responsive size-adjustable liposomes induce apoptosis of fibroblasts and macrophages for rheumatoid arthritis treatment},
  journal = {Acta Biomaterialia},
  year = {2024},
  volume = {179},
  pages = {256--271},
  doi = {10.1016/j.actbio.2024.03.006}
}
Kostenlos starten →